Investing.com - Fresenius Medical Care ADR reported on Tuesday second quarter earnings that missed analysts' forecasts and revenue that topped expectations.
Fresenius Medical Care ADR announced earnings per share of $0.3955 on revenue of $4.89B. Analysts polled by Investing.com anticipated EPS of $0.422 on revenue of $4.76B.
Fresenius Medical Care ADR shares are down 43.31% from the beginning of the year and are trading at $18.40 , down-from-52-week-high.They are under-performing the EUR/USD which is down 0% from the start of the year.
Fresenius Medical Care ADR shares gained 0.27% in intra-day trade the report.
Fresenius Medical Care ADR follows other major Healthcare sector earnings this month
Fresenius Medical Care ADR's report follows an earnings beat by UnitedHealth on Friday, July 15, 2022, who reported EPS of $5.57 on revenue of $80.33B, compared to forecasts EPS of $5.21 on revenue of $79.68B.
J&J had beat expectations on Tuesday, July 19, 2022 with second quarter EPS of $2.59 on revenue of $24.02B, compared to forecast for EPS of $2.54 on revenue of $23.77B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar